 The data from this study will be combined with the data from CANVAS-R study Study of the Effects of Canagliflozin on Renal Endpoints in Adult Subjects with T2DM, NCT01989754 in a pre-specified integrated analysis of CV safety outcomes to satisfy US FDA post-marketing requirements for canagliflozin. 